AAAAAA

   
Results: 1-25 | 26-50 | 51-53
Results: 1-25/53

Authors: Kasimir-Bauer, S Mayer, S Bojko, P Borquez, D Neumann, R Seeber, S
Citation: S. Kasimir-bauer et al., Survival of tumor cells in stem cell preparations and bone marrow of patients with high-risk or metastatic breast cancer after receiving dose-intensive or high-dose chemotherapy, CLIN CANC R, 7(6), 2001, pp. 1582-1589

Authors: Seeber, S
Citation: S. Seeber, EGFR in tumour growth: Biological role and clinical implications - Introduction, EUR J CANC, 37, 2001, pp. S1-S2

Authors: Stahl, C Kubetzko, S Kaps, I Seeber, S Engelhardt, H Niederweis, M
Citation: C. Stahl et al., MspA provides the main hydrophilic pathway through the cell wall of Mycobacterium smegmatis, MOL MICROB, 40(2), 2001, pp. 451-464

Authors: Jansen, M Bardenheuer, W Sorg, UR Seeber, S Flasshove, M Moritz, T
Citation: M. Jansen et al., Protection of hematopoietic cells from O-6-alkylation damage by O-6-methylguanine DNA methyltransferase gene transfer: studies with different O-6-alkylating agents and retroviral backbones, EUR J HAEMA, 67(1), 2001, pp. 2-13

Authors: Vanhoefer, U Harstrick, A Achterrath, W Cao, SS Seeber, S Rustum, YM
Citation: U. Vanhoefer et al., Irinotecan in the treatment of colorectal cancer: Clinical overview, J CL ONCOL, 19(5), 2001, pp. 1501-1518

Authors: Kaps, I Ehrt, S Seeber, S Schnappinger, D Martin, C Riley, LW Niederweis, M
Citation: I. Kaps et al., Energy transfer between fluorescent proteins using a co-expression system in Mycobacterium smegmatis, GENE, 278(1-2), 2001, pp. 115-124

Authors: Elmaagacli, AH Runkel, K Steckel, N Opalka, B Trenschel, R Seeber, S Schaefer, UW Beelen, DW
Citation: Ah. Elmaagacli et al., A comparison of chimerism and minimal residual disease between four different allogeneic transplantation methods in patients with chronic myelogenousleukemia in first chronic phase, BONE MAR TR, 27(8), 2001, pp. 809-815

Authors: Bojko, P Scheulen, ME Hilger, R Oberhoff, C Schindler, AD Seeber, S
Citation: P. Bojko et al., High-dose chemotherapy with peripheral blood stem cell transplantation forpatients with advanced ovarian cancer, J CANC RES, 127(4), 2001, pp. 243-250

Authors: Kasimir-Bauer, S Oberhoff, C Sliwinska, K Neumann, R Schindler, AE Seeber, S
Citation: S. Kasimir-bauer et al., Evaluation of different methods for the detection of minimal residual disease in blood and bone marrow of patients with primary breast cancer: importance for clinical use ?, BREAST CANC, 69(2), 2001, pp. 123-132

Authors: Kratzer, S Mundigl, O Dicker, F Seeber, S
Citation: S. Kratzer et al., Digital imaging microscopy of firefly luciferase activity to directly monitor differences in cell transduction efficiencies between AdCMVLuc and Ad5LucRGD vectors having different cell binding properties, J VIROL MET, 93(1-2), 2001, pp. 175-179

Authors: Bacher, G Nickel, B Emig, P Vanhoefer, U Seeber, S Shandra, A Klenner, T Beckers, T
Citation: G. Bacher et al., D-24851, a novel synthetic microtubule inhibitor, exerts curative antitumoral activity in vivo, shows efficacy toward multidrug-resistant tumor cells, and lacks neurotoxicity, CANCER RES, 61(1), 2001, pp. 392-399

Authors: Elmaagacli, AH Freist, A Hahn, M Opalka, B Seeber, S Schaefer, UW Beelen, DW
Citation: Ah. Elmaagacli et al., Estimating the relapse stage in chronic myeloid leukaemia patients after allogeneic stem cell transplantation by the amount of BCR-ABL fusion transcripts detected using a new real-time polymerase chain reaction method, BR J HAEM, 113(4), 2001, pp. 1072-1075

Authors: Trarbach, T Greifenberg, S Bardenheuer, W Elmaagacli, A Hirche, H Flasshove, M Seeber, S Moritz, T
Citation: T. Trarbach et al., Optimized retroviral transduction protocol for human progenitor cells utilizing fibronectin fragments, CYTOTHERAPY, 2(6), 2000, pp. 429-438

Authors: Scheulen, ME Hilger, RA Oberhoff, C Casper, J F'reund, M Josten, KM Bornhauser, M Ehninger, G Berdel, WE Baumgart, J Harstrick, A Bojko, P Wolf, HH Schindler, AE Seeber, S
Citation: Me. Scheulen et al., Clinical phase I dose escalation and pharmacokinetic study of high-dose chemotherapy with treosulfan and autologous peripheral blood stem cell transplantation in patients with advanced malignancies, CLIN CANC R, 6(11), 2000, pp. 4209-4216

Authors: Muller, MR Lennartz, K Baack, B Heim, MME Seeber, S Scheulen, ME
Citation: Mr. Muller et al., Simultaneous measurement of cellular P-glycoprotein content and function by multiparametric flow-cytometry, INT J CL PH, 38(4), 2000, pp. 180-186

Authors: Elmaagacli, AH Beelen, DW Opalka, B Seeber, S Schafer, UW
Citation: Ah. Elmaagacli et al., The amount of BCR-ABL fusion transcripts detected by the real-time quantitative polymerase chain reaction method in patients with Philadelphia chromosome positive chronic myeloid leukemia correlates with the disease stage, ANN HEMATOL, 79(8), 2000, pp. 424-431

Authors: Ottinger, HD Muller, C Schmitz, N Kubanek, B Arnold, R Ebell, W Eberhard, HP Ehninger, G Fronz, U Goldmann, S Grosse-Wilde, H Havers, W Klingebiel, T Kolb, HJ Seeber, S Schaefer, UW Baldomero, H Gratwohl, A
Citation: Hd. Ottinger et al., Transplant activities in Germany in 1998 - a survey facilitated by the National Registry for Hemopoietic Stem Cell Transplantation, ANN HEMATOL, 79(8), 2000, pp. 437-443

Authors: Flasshove, M Meusers, P Schutte, J Noppeney, R Beelen, DW Sohrab, S Roggenbuck, U Kemmeries, G Brittinger, G Seeber, S Scheulen, ME
Citation: M. Flasshove et al., Long-term survival after induction therapy with idarubicin and cytosine arabinoside for de novo acute myeloid leukemia, ANN HEMATOL, 79(10), 2000, pp. 533-542

Authors: Dickopp, A Esche, H Swart, G Seeber, S Kirch, HC Opalka, B
Citation: A. Dickopp et al., Transformation-defective adenovirus 5 E1A mutants exhibit antioncogenic properties in human BLM melanoma cells, CANC GENE T, 7(7), 2000, pp. 1043-1050

Authors: Seeber, S
Citation: S. Seeber, A new era in oncology, ONKOLOGIE, 23, 2000, pp. IV-IV

Authors: Vanhoefer, U Achterrath, W Wilke, H Seeber, S
Citation: U. Vanhoefer et al., Preclinical evaluation of irinotecan, ONKOLOGIE, 23, 2000, pp. S2-S7

Authors: Hilger, RA Jacek, G Oberhoff, C Kredtke, S Baumgart, J Seeber, S Scheulen, ME
Citation: Ra. Hilger et al., Investigation of bioavailability and pharmacokinetics of treosulfan capsules in patients with relapsed ovarian cancer, CANC CHEMOT, 45(6), 2000, pp. 483-488

Authors: Stuschke, M Stahl, M Wilke, H Walz, M Oldenburg, A Stuben, G Seeber, S Sack, H
Citation: M. Stuschke et al., Induction chemotherapy followed by concurrent chemotherapy and high-dose radiotherapy for locally advanced squamous cell carcinoma of the upper-thoracic and midthoracic esophagus, AM J CL ONC, 23(3), 2000, pp. 233-238

Authors: Beelen, DW Peceny, R Elmaagacli, A Ottinger, H Kummer, G Opalka, B Seeber, S Schaefer, UW
Citation: Dw. Beelen et al., Transplantation of highly purified HLA-identical sibling donor peripheral blood CD34(+) cells without prophylactic post-transplant immunosuppression in adult patients with first chronic phase chronic myeloid leukemia: results of a phase II study, BONE MAR TR, 26(8), 2000, pp. 823-829

Authors: Flasshove, M Bardenheuer, W Schneider, A Hirsch, G Bach, P Bury, C Moritz, T Seeber, S Opalka, B
Citation: M. Flasshove et al., Type and position of promoter elements in retroviral vectors have substantial effects on the expression level of an enhanced green fluorescent protein reporter gene, J CANC RES, 126(7), 2000, pp. 391-399
Risultati: 1-25 | 26-50 | 51-53